Glaxosmithkline Pharma Ltd


BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 
Market Cap: [Rs.Cr.] 16,862 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Multinational

 Discuss this stock

Profit & Loss

(Rs. in Crores)
ParticularsDec-11Dec-10Dec-09Dec-08Dec-07Dec-06
INCOME :      
Sales Turnover 2,391.732,155.081,912.771,751.561,712.841,677.57
Excise Duty53.7043.4440.1286.27142.54139.15
Net Sales2,338.032,111.641,872.651,665.291,570.301,538.42
Other Income 199.21147.73152.87310.70338.52295.18
Stock Adjustments 56.0920.1932.412.32-16.8022.58
Total Income2,593.332,279.562,057.931,978.311,892.021,856.18
EXPENDITURE :      
Raw Materials 964.60797.19724.63649.93611.66647.10
Power & Fuel Cost26.7026.7524.6624.7520.5419.23
Employee Cost 279.48234.53203.98168.36148.07151.45
Other Manufacturing Expenses 74.5064.6959.6752.3551.2347.76
Selling and Administration Expenses 277.03246.75219.69201.07197.24180.65
Miscellaneous Expenses 351.2250.6335.3062.7155.2453.23
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1,973.531,420.541,267.931,159.171,083.981,099.42
Operating Profit619.80859.02790.00819.14808.04756.76
Interest 0.330.620.370.530.631.35
Gross Profit619.47858.40789.63818.61807.41755.41
Depreciation20.4117.6316.3716.3416.1615.85
Profit Before Tax599.06840.77773.26802.27791.25739.56
Tax180.68288.78274.22228.00234.86182.10
Fringe Benefit tax-7.150.001.857.156.806.80
Deferred Tax-5.07-11.70-15.10-9.4511.935.15
Reported Net Profit430.60563.69512.29576.57537.66545.51
Extraordinary Items -160.23-17.049.7887.87142.29188.39
Adjusted Net Profit590.83580.73502.51488.70395.37357.12
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward1,164.531,049.23882.41759.89632.75441.19
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 484.54448.39345.47454.05410.52353.95
P & L Balance carried down1,110.591,164.531,049.23882.41759.89632.75
Dividend381.16338.81254.11338.81304.93262.58
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %450.00400.00300.00400.00360.00310.00
Earnings Per Share-Unit Curr43.7260.2755.7461.2757.3660.06
Earnings Per Share(Adj)-Unit Curr43.7260.2755.7461.2757.3660.06
Book Value-Unit Curr226.67227.96207.69181.95160.68141.05

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Glaxosmit Pharma 16,861.65 26.69 8.78 23.27 30.7 47.7 0.00
Sanofi India 4,783.79 26.47 4.33 16.19 18.2 27.0 0.00
Astrazeneca Phar 4,697.00 237.52 24.81 27.64 31.7 49.8 0.00
Pfizer 3,488.45 18.87 2.67 8.63 15.7 24.0 0.00
Abbott India 3,133.74 26.67 5.76 14.58 28.3 42.4 0.00
Novartis India 2,355.93 15.50 2.88 8.97 22.6 33.8 0.00
Wyeth 1,980.28 13.69 4.05 6.89 37.4 53.1 0.01
Merck 960.73 18.09 2.34 8.45 16.8 25.3 0.00
Fulford (India) 253.50 0.00 1.69 12.29 1.2 1.9 0.00
Organon (India) 159.14 0.00 0.98 0.00 15.3 22.8 0.00

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

D S Parekh , Chairman 

V Thyagarajan , Vice Chairman 

H B Joshipura , Managing Director 

R R Bajaaj , Director 


Company Head Office / Quarters:
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030
Phone : 91-022-24959595
Fax : 91-022-24959494
E-mail : ajay.a.nadkarni@gsk.com
Web : http://www.gsk-india.com
Registrars:
Karvy Computershare Pvt Ltd
Plot No 17-24
Vittal Rao Nagar
Madhapur
Hyderabad-500081

Calendar

May-2012
M T W T F S S
21 22 23 24 25 26 27
IPO
listNo IPO today
Economic Events
list No economic event today
Results
list No result today